Skip to content

← All stories

Markets

Neurocrine starts phase 1 trial of obesity drug candidate

1 source ·1 article ·12h ago

Covered by 1 outlet

All coverage · 1 article

Investing.com Canada ·12h ago

Neurocrine starts phase 1 trial of obesity drug candidate